Peptide Intelligence

Peptides, scored by the evidence

See which peptides the evidence backs, what each is researched for, and its US status.

  • 57BioHarmony scores
  • 95compounds
  • Everyentry sourced

95 compoundsranked by score

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
  4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.
  5. 7.2/10Thymosin Beta-4 (Full)Strong recommendRecoveryInvestigational
  6. 7.1/10KPV (Lysine-Proline-Valine)Strong recommendRecoveryNot FDA approvedKPV is a three-amino-acid alpha-MSH fragment that reduced inflammation in mouse colitis models through PepT1 uptake and NF-kB pathway suppression, but it still has zero…
  7. 7.1/10SemaxStrong recommendRecoveryNot FDA approvedSemax is a Russian-developed ACTH 4-7 + PGP heptapeptide with the strongest human signal in post-stroke recovery, including a 110-patient Gusev et al.
  8. 6.9/10SelankWorth tryingBrain & sleepNot FDA approvedSelank is a synthetic tuftsin-derived heptapeptide studied as a non-sedating anxiolytic.
  9. 6.7/10Epitalon (Epithalon)Worth tryingBrain & sleepNot FDA approvedEpitalon is a synthetic AEDG tetrapeptide with in vitro telomerase and telomere data, animal lifespan signals, and Russian pineal-peptide melatonin studies.
  10. 6.6/10ThymulinWorth tryingLongevityInvestigationalThymulin (zinc-thymulin) is a chemically defined, zinc-dependent thymic nonapeptide hormone with deep classical immunology behind it but no modern human trial of the…
  11. 6.5/10AHK-Cu (Copper Tripeptide)Worth tryingSkin & hairInvestigationalAHK-Cu is a topical copper tripeptide, Alanine-Histidine-Lysine plus copper, marketed for hair growth.
  12. 6.5/10ARA-290Worth tryingRecoveryInvestigationalARA-290 (cibinetide) is an EPO-derived peptide that activates the innate repair receptor to regrow small nerve fibers without EPO's blood effects.
  13. 6.5/10MOTS-cWorth tryingWeight & metabolicNot FDA approvedMOTS-c is a 16-amino-acid mitochondrial-derived peptide discovered in Lee 2015 that activates AMPK through the folate and purine pathway.
  14. 6.5/10OxytocinWorth tryingFDA-approved product existsIntranasal oxytocin is the endogenous bonding hormone used off-label as a nasal spray for social connection, anxiety, and libido.
  15. 6.4/10Kisspeptin-10Worth tryingGH & hormonesNot FDA approvedKisspeptin-10 is an investigational reproductive neuropeptide that activates the HPG axis through the KISS1R receptor.
  16. 6.4/10PinealonWorth tryingBrain & sleepNot FDA approvedPinealon (Glu-Asp-Arg, or EDR) is a synthetic Khavinson tripeptide marketed for neuroprotection and cognition.
  17. 6.4/10VilonWorth tryingLongevityNot FDA approvedVilon is the Lysine-Glutamic acid (KE) dipeptide from Vladimir Khavinson's bioregulator program, sold for immune restoration and anti-aging.
  18. 6.3/10CerebrolysinWorth tryingRecoveryNot FDA approvedCerebrolysin is a porcine brain-derived peptide mixture given by IV or IM infusion.
  19. 6.3/10Gonadorelin (GnRH)Worth tryingGH & hormonesFDA-approved product existsGonadorelin is synthetic GnRH, a decapeptide that tells the pituitary to release LH and FSH.
  20. 6.2/10IpamorelinWorth tryingRecoveryNot FDA approvedIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…
  21. 6.2/10Melanotan IWorth tryingSkin & hairFDA-approved product existsMelanotan I is most defensible for photoprotection in EPP and planned UV exposure, with Langendonk 2015 reporting 69.4 vs 40.8 hours of pain-free sun exposure in the US…
  22. 6.2/10SNAP-8Worth tryingSkin & hairNot FDA approvedSNAP-8 (acetyl octapeptide-3) is a topical cosmetic peptide sold as a Botox alternative.
  23. 6.1/10DSIP (Delta Sleep Inducing Peptide)Worth tryingRecoveryNot FDA approvedDSIP (Delta Sleep-Inducing Peptide) is a naturally-occurring nonapeptide whose famous name oversells it.
  24. 6.1/10TirzepatideWorth tryingWeight & metabolicFDA-approved product existsTirzepatide is a once-weekly subcutaneous dual GIP plus GLP-1 receptor agonist with unusually large weight-loss and glycemic effects.
  25. 6.0/10Semaglutide (GLP-1 Agonist)Worth tryingWeight & metabolicFDA-approved product existsSemaglutide is a prescription GLP-1 receptor agonist that produced 14.9% mean weight loss in STEP-1 and cut 3-point MACE by 20% in SELECT, but the 6.0-6.5/10 score holds…
  26. 6.0/10SS-31 (Elamipretide)Worth tryingRecoveryFDA-approved product existsSS-31 (elamipretide) is a mitochondria-targeting tetrapeptide that binds cardiolipin.
  27. 6.0/10TesamorelinWorth tryingWeight & metabolicFDA-approved product existsTesamorelin is a stabilized GHRH analog that reduced visceral adipose tissue in the landmark Falutz 2007 HIV lipodystrophy Phase 3 trial and has newer support for…
  28. 5.9/10SermorelinWorth tryingRecoveryFDA-approved product existsSermorelin (GHRH 1-29) is a short-acting peptide that prompts your own pituitary to release growth hormone, and it is the only one in its class with a former FDA…
  29. 5.9/10ThymalinWorth tryingLongevityNot FDA approvedThymalin is a thymic peptide complex with published laboratory research and Russian clinical literature. The reviewed sources do not establish an FDA-approved U.S.
  30. 5.8/10CagrilintideWorth tryingWeight & metabolicInvestigationalCagrilintide (AM833) is a long-acting amylin receptor analogue that drove about 11.8 percent weight loss as monotherapy at 68 weeks in REDEFINE 1 per Garvey 2025, with…
  31. 5.8/10CJC-1295 No DAC (Mod GRF 1-29)Worth tryingRecoveryNot FDA approvedCJC-1295 No DAC (Mod GRF 1-29) is a short-acting GHRH peptide, almost always stacked with ipamorelin, that prompts a pulse of your own growth hormone.
  32. 5.8/10OrforglipronWorth tryingWeight & metabolicFDA-approved product existsOrforglipron (Foundayo) is the first FDA-approved non-peptide oral GLP-1 pill, cleared for obesity in April 2026.
  33. 5.8/10VK2735Worth tryingWeight & metabolicInvestigationalVK2735 is an investigational dual GLP-1 and GIP receptor agonist from Viking Therapeutics that produced about 14.7 percent weight loss at 13 weeks in its peer-reviewed…
  34. 5.6/10MazdutideNeutralWeight & metabolicNot FDA approvedMazdutide (IBI362) is the first GLP-1 plus glucagon dual agonist approved anywhere, cleared in China for obesity in June 2025.
  35. 5.6/10RetatrutideNeutralWeight & metabolicInvestigationalRetatrutide is Lilly's investigational once-weekly GLP-1/GIP/glucagon triple agonist.
  36. 5.5/10GHRP-2 (Pralmorelin)NeutralRecoveryNot FDA approvedGHRP-2 (pralmorelin) is a ghrelin-receptor peptide that drives a strong growth-hormone pulse, approved in Japan since 2004 as a diagnostic test.
  37. 5.5/10HumaninNeutralWeight & metabolicInvestigationalHumanin is a 24-amino-acid mitochondrial-derived peptide that declines with age and runs much higher in children of centenarians, per Yen 2020, but it scores Neutral…
  38. 5.4/10PT-141 (Bremelanotide)NeutralGH & hormonesFDA-approved product existsPT-141 (bremelanotide) is the only FDA-approved drug for low sexual desire in premenopausal women (Vyleesi, 2019).
  39. 5.4/10VIP (Vasoactive Intestinal Peptide)NeutralImmune & gutNot FDA approvedVIP, or vasoactive intestinal peptide, is the endogenous neuropeptide whose synthetic form is aviptadil, used off-label for anti-inflammatory, immune, respiratory, and…
  40. 5.1/10CagriSemaNeutralWeight & metabolicInvestigationalCagriSema is an investigational once-weekly amylin plus GLP-1 injectable that produced about 22.7% weight loss on-treatment in REDEFINE 1, per Garvey 2025 in NEJM.
  41. 5.1/10GHRP-6NeutralRecoveryNot FDA approvedGHRP-6 is a synthetic peptide that activates the ghrelin receptor to release a pulse of your own growth hormone.
  42. 5.1/10SurvodutideNeutralWeight & metabolicInvestigationalSurvodutide (BI 456906) is an investigational once-weekly GLP-1 and glucagon dual agonist that drove up to 16.6% weight loss in Phase 3, per the Boehringer Ingelheim…
  43. 5.0/10BAM15NeutralWeight & metabolicInvestigationalBAM15 is an experimental mitochondrial uncoupler that reversed diet-induced obesity and insulin resistance in mice without raising body temperature, the effect that made…
  44. 5.0/10NAD+NeutralNot FDA approvedNAD+ (Direct) is the central redox coenzyme given by IV, injection, sublingual, or intranasal route, and it scores 5.0-5.5/10 because the human evidence is a single…
  45. 5.0/10P21 (P021)NeutralBrain & sleepInvestigationalP21 (P021) is a CNTF-derived peptidomimetic that crosses the blood-brain barrier and, in mice, raises BDNF, lifts hippocampal neurogenesis, and lowers tau pathology in…
  46. 5.0/10TesofensineNeutralWeight & metabolicInvestigationalTesofensine has completed Phase 3 obesity studies in Mexico through Saniona's partner Medix.
  47. 4.9/105-Amino-1MQNeutralRecoveryInvestigational5-Amino-1MQ is a synthetic NNMT-inhibitor research compound that cut fat mass in obese mice and raised NAD+ in cultured fat cells (Neelakantan 2018), but it has zero…
  48. 4.9/10Ibutamoren (MK-677)NeutralRecoveryNot FDA approvedMK-677 (ibutamoren) is an oral, once-daily growth-hormone secretagogue that raises IGF-1 by about 50 to 97 percent and adds roughly 1.1 kg of fat-free mass, per the Nass…
  49. 4.9/10PE-22-28 (Spadin)NeutralBrain & sleepInvestigationalPE-22-28 is a synthetic spadin analogue that blocks the TREK-1 potassium channel, a target with a clean and well-characterized link to fast-acting antidepressant effects…
  50. 4.7/10LL-37 (Cathelicidin)NeutralRecoveryNot FDA approvedLL-37 (Cathelicidin) is the only human cathelicidin antimicrobial peptide, with a rich antimicrobial and wound-healing mechanism but thin human therapy data: one small…
  51. 4.7/10Pentosan Polysulfate (PPS)NeutralRecoveryFDA-approved product existsPentosan polysulfate (oral Elmiron) is an FDA-approved sulfated polysaccharide drug for interstitial cystitis bladder pain, sometimes used off-label for joints.
  52. 4.7/10SLU-PP-332NeutralWeight & metabolicInvestigationalSLU-PP-332 is a synthetic pan-ERR agonist developed in the Thomas Burris lab. Billon et al.
  53. 4.5/10Melanotan IINeutralWeight & metabolicNot FDA approvedMelanotan II is a fast tanning and sexual-response peptide with a harsher safety tradeoff; Nelson 2012 reported rhabdomyolysis after a 6 mg injection.
  54. 4.4/10CJC-1295 DACCautionRecoveryNot FDA approvedCJC-1295 with DAC is the long-acting form, dosed about weekly, that keeps growth hormone elevated for 6 to 8 days.
  55. 4.4/10DihexaCautionBrain & sleepNot FDA approvedDihexa is a gray-market angiotensin IV analog with rodent synaptogenesis and memory data, including McCoy 2013 and Sun 2021, but zero human trials, no human…
  56. 4.1/10FOX04-DRICautionLongevityInvestigationalFOXO4-DRI is a designed senolytic peptide that kills senescent cells by breaking the FOXO4 to p53 bond, famous for restoring fur and kidney function in aged mice per…
  57. 3.0/10AOD-9604CautionRecoveryNot FDA approvedAOD-9604 is a human growth hormone fragment (hGH 176 to 191) marketed for fat loss, but its only controlled human weight-loss program failed to beat placebo, per the…
  58. Not yet scoredAbaloparatide (Tymlos)RecoveryFDA-approved product existsFDA-approved abaloparatide is marketed as Tymlos for specified women and men with osteoporosis at high fracture risk or who have failed or cannot tolerate other therapy.
  59. Not yet scoredATX-304 (O-304)Weight & metabolicInvestigationalAmplifier Therapeutics describes ATX-304, also known as O-304, as an oral small-molecule pan-AMPK activator in Phase 2 development.
  60. Not yet scoredB7-33LongevityInvestigationalB7-33 is a preclinical single-chain relaxin-family peptide agonist studied for selective antifibrotic signaling in animal models.
  61. Not yet scoredBerobenatide (MET-097i / PF-08653944)Weight & metabolicInvestigational
  62. Not yet scoredCalcitonin SalmonRecoveryFDA-approved product existsFDA-approved calcitonin salmon products exist in nasal and injectable formulations for product-specific bone and calcium disorders.
  63. Not yet scoredDesmopressinGH & hormonesFDA-approved product existsFDA-approved desmopressin formulations exist for product-specific uses including central diabetes insipidus and specified bleeding disorders; routes and strengths are…
  64. Not yet scoredDulaglutide (Trulicity)Weight & metabolicFDA-approved product existsFDA-approved dulaglutide is marketed as Trulicity for improving glycemic control in adults and children 10 years and older with type 2 diabetes, with additional labeled…
  65. Not yet scoredEnicepatide (CT-388)Weight & metabolicInvestigational
  66. Not yet scoredExenatideWeight & metabolicFDA-approved product existsFDA-approved exenatide products exist for improving glycemic control in specified patients with type 2 diabetes.
  67. Not yet scoredGlucagonWeight & metabolicFDA-approved product existsMultiple FDA-approved glucagon rescue products exist for severe hypoglycemia. Formulations include ready-to-use solutions and products requiring preparation, with…
  68. Not yet scoredGoserelin (Zoladex)GH & hormonesFDA-approved product existsFDA-approved goserelin is marketed as Zoladex implants for product-specific uses in prostate cancer, breast cancer, endometriosis, and endometrial thinning.
  69. Not yet scoredHistrelin (Supprelin LA)GH & hormonesFDA-approved product existsFDA-approved histrelin is marketed as Supprelin LA, a 12-month implant for children with central precocious puberty.
  70. Not yet scoredIcatibant (Firazyr)Immune & gutFDA-approved product existsFDA-approved icatibant is marketed as Firazyr for treatment of acute hereditary angioedema attacks in adults 18 years and older.
  71. Not yet scoredLanreotideGH & hormonesFDA-approved product existsFDA-approved lanreotide products exist for long-term treatment of acromegaly and for specified gastroenteropancreatic neuroendocrine tumors.
  72. Not yet scoredLeuprolideGH & hormonesFDA-approved product existsMultiple FDA-approved leuprolide formulations exist. Their indications, release periods, doses, and preparation requirements are product-specific and not interchangeable.
  73. Not yet scoredLinaclotide (Linzess)Immune & gutFDA-approved product existsFDA-approved linaclotide is marketed as Linzess for irritable bowel syndrome with constipation and chronic idiopathic constipation, with age- and indication-specific…
  74. Not yet scoredLiraglutideWeight & metabolicFDA-approved product exists
  75. Not yet scoredLixisenatideWeight & metabolicFDA-approved product existsLixisenatide is a component of FDA-approved Soliqua 100/33, a fixed-ratio insulin glargine and lixisenatide product for improving glycemic control in adults with type 2…
  76. Not yet scoredMaridebart Cafraglutide (MariTide)Weight & metabolicInvestigational
  77. Not yet scoredNavepegritide (Yuviwel)GH & hormonesFDA-approved product existsFDA granted accelerated approval to Yuviwel (navepegritide) in February 2026 for certain pediatric patients with achondroplasia; continued approval depends on…
  78. Not yet scoredOctreotideGH & hormonesFDA-approved product existsFDA-approved octreotide products exist for acromegaly and severe diarrhea or flushing associated with specified tumors; dosing and preparation vary by formulation.
  79. Not yet scoredP110Brain & sleepInvestigationalP110 is a preclinical peptide inhibitor of the stress-associated Drp1-Fis1 interaction. Recent animal and cell studies do not establish human safety or effectiveness.
  80. Not yet scoredPasireotide (Signifor)GH & hormonesFDA-approved product existsFDA-approved pasireotide is marketed as Signifor for specified adults with Cushing disease; a long-acting formulation has a separate label for specified uses.
  81. Not yet scoredPEG-MGFRecoveryNot FDA approvedFDA says compounded PEG-MGF may pose immunogenicity, impurity, and characterization risks and that it has identified no human exposure data for PEG-MGF administered by…
  82. Not yet scoredPemvidutideWeight & metabolicInvestigational
  83. Not yet scoredPetrelintideWeight & metabolicInvestigational
  84. Not yet scoredPlecanatide (Trulance)Immune & gutFDA-approved product existsFDA-approved plecanatide is marketed as Trulance for chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.
  85. Not yet scoredPramlintide (SymlinPen)Weight & metabolicFDA-approved product existsFDA-approved pramlintide is marketed as SymlinPen as an adjunct to mealtime insulin in specified adults with type 1 or type 2 diabetes who have not achieved desired…
  86. Not yet scoredRusfertide (PTG-300)InvestigationalRusfertide is an investigational hepcidin mimetic peptide studied in Phase 3 for polycythemia vera.
  87. Not yet scoredSetmelanotide (Imcivree)Weight & metabolicFDA-approved product existsFDA-approved setmelanotide is marketed as Imcivree for chronic weight management in patients with obesity caused by specific rare genetic conditions covered by the label.
  88. Not yet scoredTeduglutide (Gattex)Immune & gutFDA-approved product existsFDA-approved teduglutide is marketed as Gattex for adults and pediatric patients one year and older with short bowel syndrome who are dependent on parenteral support.
  89. Not yet scoredTeriparatideRecoveryFDA-approved product existsFDA-approved teriparatide products exist for specified women and men with osteoporosis at high fracture risk and for glucocorticoid-associated osteoporosis in specified…
  90. Not yet scoredTerlipressin (Terlivaz)FDA-approved product existsFDA-approved terlipressin is marketed as Terlivaz to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.
  91. Not yet scoredTriptorelin (Trelstar)GH & hormonesFDA-approved product existsFDA-approved triptorelin is marketed as Trelstar depot formulations for palliative treatment of advanced prostate cancer, with product-specific dosing intervals.
  92. Not yet scoredUBT251Weight & metabolicInvestigationalNovo Nordisk reports that a Phase 1a/2b trial has started for UBT251, an investigational triple agonist.
  93. Not yet scoredVosoritide (Voxzogo)GH & hormonesFDA-approved product existsFDA-approved vosoritide is marketed as Voxzogo to increase linear growth in pediatric patients with achondroplasia and open epiphyses.
  94. Not yet scoredZenagamtide (Amycretin)Weight & metabolicInvestigational
  95. Not yet scoredZiconotide (Prialt)FDA-approved product existsFDA-approved ziconotide is marketed as Prialt for severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to…

How to read this database

BioHarmony score

Outliyr's 0 to 10 rating of benefit, risk, and evidence.

Not yet scored

No report yet. Review queued; status and sources still apply.

Trust & sourcing

US status, review dates, and sources on every page.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.